Bibliometric analysis of global scientific research on COVID-19

J Biosaf Biosecur. 2021 Jun;3(1):4-9. doi: 10.1016/j.jobb.2020.12.002. Epub 2021 Jan 23.

Abstract

Since the outbreak of coronavirus disease 2019 (COVID-19), a large number of COVID-19-related reports have been published in journals or submitted to preprint platforms. In this study, we search the COVID-19-related literature officially published and included in the Web of Science (WOS) database or submitted to four preprint platforms: bioRxiv, medRxiv, Preprints, and SSRN. Using data on the number of reports, author institution, country, and research category, we analyze global trends in COVID-19 research, including institution distribution and research hotspots. The results show that a large number of COVID-19-related reports have been produced; the United States has contributed the most published literature, followed by China. The United States has published the most reports included in the WOS in the categories of non-pharmaceutical interventions, treatment, and vaccine-related reports, while China has published the most literature in the categories of clinical features and complications, virology and immunology, epidemiology, and detection and diagnosis. Publication countries are concentrated in Asia, North America, and Europe, while South America and Africa have less literature. In conclusion, many scientific research issues related to COVID-19 need to be further clarified and COVID-19 research urgently needs global cooperation.

Keywords: Bibliometric; COVID-19; Preprint; Web of Science.